ESC Professional Premium Access

Similar heart failure hospitalization and survival benefits are associated with Sacubitril/Valsartan therapy in CRT non responders and in HFrEF patients with no CRT indication

Congress Presentation

About the speaker

Doctor Krisztina Szabo

University of Debrecen, Debrecen (Hungary)
0 follower

6 more presentations in this session

Real-world drug prescription patterns and mortality risk in patients hospitalized with acute heart hailure: impact of multimorbidity and heart failure phenotype

Speaker: Professor C. Angermann (Wurzburg, DE)


The effectiveness of eplerenone vs spironolactone on left ventricular systolic function, hospitalization and cardiovascular death in patients with chronic heart failure - HFrEF

Speaker: Associate Professor N. Naser (Sarajevo, BA)


Heart rate reduction and outcomes in heart failure outpatients

Speaker: Doctor F. Memenga (Hamburg, DE)


Impact of the role of cardiology pharmacy specialist on the improvement of quality indicators among patients with heart failure and reduced ejection fraction

Speaker: Professor H. Al Farhan (Baghdad, IQ)


The effect of long-term application of guideline-directed medical therapy on systolic blood pressure in hospitalized patients with heart failure with reduced ejection fraction

Speaker: Doctor F. Banfi-Bacsardi (Budapest, HU)


Access the full session

Clinical heart failure from diagnostics to treatment

Speakers: Doctor K. Szabo, Professor C. Angermann, Associate Professor N. Naser, Doctor F. Memenga, Professor H. Al Farhan...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by